Lea Hachigian

Lea Hachigian serves as Vice President of Strategy & Operations at Be Biopharma, focusing on strategic development and overseeing the Allo Pipeline Program since September 2020. Hachigian co-founded Longwood Fund, a biotech venture capital firm, where responsibilities include deal sourcing and supporting portfolio companies. Previous roles include founding CEO at ImmuneID and director positions at Immunitas Therapeutics, TScan Therapeutics, and Bicycle Therapeutics. Hachigian's academic background includes a PhD in Molecular and Cellular Neuroscience from the Massachusetts Institute of Technology and a BA in Neurobiology from Harvard University.